Company Filing History:
Years Active: 2006
Title: Innovations of Peter S Holton in Ion Separation Technologies
Introduction
Peter S Holton is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of ion separation technologies, particularly in the context of metallic elements in aqueous solutions. His innovative approaches have the potential to enhance various applications in the pharmaceutical and medical industries.
Latest Patents
Holton holds a patent for a "Method and apparatus for separating ions of metallic elements in aqueous solution." This patent describes methods that utilize a hydrophobic chelating extractant, such as an organophosphorus compound, adsorbed onto carbon or graphite fibers in the form of felt. The invention also includes a new thallium-201 generator that comprises a column containing an acidic organophosphorus extractant adsorbed on carbon or graphite fibers. Additionally, it features a yttrium-90 generator system designed to selectively absorb yttrium-90 at different pH levels, enabling the separation of yttrium-90 from strontium-90. The two columns are connected in series for stepwise separation, allowing for the efficient elution of the yttrium-90 product from the second column with various solvents. Furthermore, the patent outlines a new technetium generator that selectively absorbs molybdenum at a chosen pH, facilitating the separation of technetium from molybdenum.
Career Highlights
Peter S Holton is currently associated with Bristol-Myers Squibb Pharma Company, where he continues to innovate and develop new technologies. His work has been instrumental in advancing the methods used for ion separation, which are crucial for various medical applications.
Collaborations
Holton has collaborated with notable colleagues, including Robert E Lewis and Fu-Min Su. Their combined expertise has contributed to the successful development of innovative solutions in the field of ion separation.
Conclusion
Peter S Holton's contributions to ion separation technologies demonstrate his commitment to advancing scientific knowledge and practical applications in the pharmaceutical industry. His innovative methods and collaborative efforts continue to pave the way for future advancements in this critical field.